Complications of catheter-based therapies for structural heart disease and safely manage them with various procedural techniques
Appropriate multidisciplinary team, imaging technologies and catheter equipment to perform structural heart disease interventions
Current clinical data in order to optimize the treatment of patients with aortic stenosis, mitral regurgitation and atrial fibrillation
Assessment of the aortic, mitral, and tricuspid valves, and the interatrial septum, using echocardiography (TTE, TEE and ICE), CT, and MRI for the purpose of the interventional treatment of these cardiac structures
Current indications for catheter-based techniques, including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair/replacement, left atrial appendage closure, ASD, and paravalvular leaks
Tricuspid anatomy and function and assess the implications of tricuspid regurgitation and transcatheter techniques for transcatheter tricuspid valve repair
Integrate emerging data into TAVR decision-making regarding surgical risk, including low and intermediate-risk patients
The patient with cryptogenic stroke and identify the patient in whom PFO closure is appropriate
Integrate basic and advanced imaging and catheter techniques for transeptal puncture for the purpose of LAA closure, transcatheter mitral valve repair and paravalvular leak closure
CT imaging before and after LAA closure
Echocardiographic findings to determine optimal strategy for transcatheter mitral valve repair
Select the appropriate type and size device for TAVR, LAA closure, PFO closure, and other structural interventions
Avoiding common pitfalls in the application of the newer imaging modalities
Advanced techniques for transcatheter mitral valve repair, TAVR, PFO, ASD, and LAA closure in the setting of challenging anatomy and/or patient co-morbidities
Venue
Hyatt Regency La Jolla at Aventine ,
3777 La Jolla Village Drive, La Jolla, California, United States
